La Tour de Peilz, Switzerland

Loïc Tomas


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Loïc Tomas: Innovator in mTOR Inhibitor Compounds

Introduction

Loïc Tomas is a notable inventor based in La Tour de Peilz, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of mTOR inhibitors. With a total of 2 patents to his name, Tomas is recognized for his innovative approach to drug development.

Latest Patents

Tomas's latest patents include "Substituted pyrazolo[3,4-d]pyrimidines as mTOR inhibitors." This invention relates to novel mTOR inhibitor compounds that possess a specific formula or a pharmaceutically acceptable salt thereof. The patent also covers compositions comprising these mTOR inhibitor compounds, methods for producing them, and their use in therapeutic applications. Another significant patent is focused on mTOR inhibitor compounds with a general formula, which also includes compositions, production methods, and their application as drugs.

Career Highlights

Throughout his career, Loïc Tomas has worked with prominent organizations such as Galderma Research & Development and the Centre National de la Recherche Scientifique. His work in these institutions has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Tomas has collaborated with esteemed colleagues, including Laurence Clary and Jean-François Fournier. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.

Conclusion

Loïc Tomas is a distinguished inventor whose work in mTOR inhibitors has the potential to influence the pharmaceutical industry significantly. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…